Skip to main content
OpenTrials
Completed

NCT Number: NCT03548623

Patient Preference in Blood Pressure Therapy

Written surveys of patients with high blood pressure are designed to determine how they would likely decide if, in addition to taking medication, they had another option to treat their hypertension.

The alternative treatment option is renal sympathetic denervation using catheter ablation. This new treatment method is not yet used in the standard care. Currently, studies are being conducted in specific centers to demonstrate the efficacy of this treatment.

Questionnaires are used to determine the preference of patients for one or the other option of hypertension treatment. So far, there are no findings.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Institute for Preventive Medicine

Nuremberg, 90471, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • untreated Hypertension
  • treated Hypertension with one or more medications

Exclusion criteria

  • illiteracy

Treatment and study plan

Primary outcomes

  1. Preference of treatment

    Time frame: 3 months

    Questionnaires

Sponsors and collaborators

Lead sponsor

Roland E. Schmieder

Other

Collaborators

  • Institute for Preventive Medicine

Registry information

Official study title

Patient Preference in Blood Pressure Therapy: Questioning of Patients With Hypertension

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jun 7, 2018
Registry last updated
Feb 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.